A Study Comparing The Efficacy, Safety And Tolerability Of Latanoprost 75, 100 And 125 ug/ml To Xalatan In The Treatment Of Primary Open-Angle Glaucoma And Ocular Hypertension

Clinical trial NCT01379144 · COMPLETED

Trial details

NCT number: NCT01379144
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Open Angle Glaucoma Ocular Hypertension

Start date: 2003-01-01
Primary completion: 2003-03-01
Enrollment: 282

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.